Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab

L Gossec; T K Kvien; Philip G. Conaghan; M. Østergaard; J. Cañete; C. Gaillez; S. Mpofu; Emma E Davenport; S. Jugl

doi:10.1136/annrheumdis-2016-eular.2052

Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab

L Gossec, T K Kvien, Philip G. Conaghan, M. Østergaard, J. Cañete, C. Gaillez, S. Mpofu, Emma E Davenport, S. Jugl

Department of Clinical Medicine

Original language	English
Article number	THU0442
Journal	Annals of the Rheumatic Diseases
Volume	75
Issue number	Suppl 2
Number of pages	1
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2016-eular.2052
Publication status	Published - 2016

Access to Document

10.1136/annrheumdis-2016-eular.2052

Cite this

Gossec, L., Kvien, T. K., Conaghan, P. G., Østergaard, M., Cañete, J., Gaillez, C., Mpofu, S., Davenport, E. E., & Jugl, S. (2016). Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab. Annals of the Rheumatic Diseases, 75(Suppl 2), [THU0442]. https://doi.org/10.1136/annrheumdis-2016-eular.2052

Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years : Long-Term Results of Two Phase 3 Studies with Secukinumab. / Gossec, L; Kvien, T K; Conaghan, Philip G. et al.

In: Annals of the Rheumatic Diseases, Vol. 75, No. Suppl 2, THU0442, 2016.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Gossec, L, Kvien, TK, Conaghan, PG, Østergaard, M, Cañete, J, Gaillez, C, Mpofu, S, Davenport, EE & Jugl, S 2016, 'Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab', Annals of the Rheumatic Diseases, vol. 75, no. Suppl 2, THU0442. https://doi.org/10.1136/annrheumdis-2016-eular.2052

@article{8b2a0ff642b34ebbb5c01ef27a24ee2e,

title = "Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab",

author = "L Gossec and Kvien, {T K} and Conaghan, {Philip G.} and M. {\O}stergaard and J. Ca{\~n}ete and C. Gaillez and S. Mpofu and Davenport, {Emma E} and S. Jugl",

year = "2016",

doi = "10.1136/annrheumdis-2016-eular.2052",

language = "English",

volume = "75",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl 2",

}

TY - ABST

T1 - Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years

T2 - Long-Term Results of Two Phase 3 Studies with Secukinumab

AU - Gossec, L

AU - Kvien, T K

AU - Conaghan, Philip G.

AU - Østergaard, M.

AU - Cañete, J.

AU - Gaillez, C.

AU - Mpofu, S.

AU - Davenport, Emma E

AU - Jugl, S.

PY - 2016

Y1 - 2016

U2 - 10.1136/annrheumdis-2016-eular.2052

DO - 10.1136/annrheumdis-2016-eular.2052

M3 - Conference abstract in journal

SN - 0003-4967

VL - 75

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

M1 - THU0442

ER -